Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127398391 | 12739839 | 1 | I | 20160826 | 0 | 20160910 | 20160910 | DIR | FDA-CTU | 11.90 | YR | F | N | 127.10000 | KG | 20160909 | N | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127398391 | 12739839 | 1 | PS | ONCASPAR | PEGASPARGASE | 1 | D | D | 0 | 4027.5 | MG | ||||||||
127398391 | 12739839 | 2 | SS | CYTARABINE. | CYTARABINE | 1 | 0 | 70 | MG | ||||||||||
127398391 | 12739839 | 3 | SS | DAUNORUBICIN | DAUNORUBICIN | 1 | 0 | 160 | MG | ||||||||||
127398391 | 12739839 | 4 | SS | METHOTREXATE. | METHOTREXATE | 1 | 0 | 15 | MG | ||||||||||
127398391 | 12739839 | 5 | SS | PREDNISONE. | PREDNISONE | 1 | 0 | 1710 | MG |
Indications of drugs used
no results found |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127398391 | 12739839 | DE |
127398391 | 12739839 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127398391 | 12739839 | Acute kidney injury | |
127398391 | 12739839 | Bacteraemia | |
127398391 | 12739839 | Bacteroides test positive | |
127398391 | 12739839 | Cardio-respiratory arrest | |
127398391 | 12739839 | Coagulopathy | |
127398391 | 12739839 | Colitis | |
127398391 | 12739839 | Condition aggravated | |
127398391 | 12739839 | Disseminated intravascular coagulation | |
127398391 | 12739839 | Dysarthria | |
127398391 | 12739839 | Enterococcus test positive | |
127398391 | 12739839 | Fatigue | |
127398391 | 12739839 | Fungaemia | |
127398391 | 12739839 | Glucose tolerance impaired | |
127398391 | 12739839 | Hepatic function abnormal | |
127398391 | 12739839 | Hepatomegaly | |
127398391 | 12739839 | Hypoglycaemia | |
127398391 | 12739839 | Hypotension | |
127398391 | 12739839 | Incoherent | |
127398391 | 12739839 | Jaundice | |
127398391 | 12739839 | Kussmaul respiration | |
127398391 | 12739839 | Lactic acidosis | |
127398391 | 12739839 | Mental status changes | |
127398391 | 12739839 | Metabolic acidosis | |
127398391 | 12739839 | Nausea | |
127398391 | 12739839 | Neutropenia | |
127398391 | 12739839 | Pulmonary haemorrhage | |
127398391 | 12739839 | Sepsis | |
127398391 | 12739839 | Thrombocytopenia | |
127398391 | 12739839 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
Event ID | CASEID | RPSR COD |
---|---|---|
127398391 | 12739839 | HP |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127398391 | 12739839 | 1 | 20160828 | 0 | ||
127398391 | 12739839 | 2 | 20160801 | 0 | ||
127398391 | 12739839 | 3 | 20160824 | 0 | ||
127398391 | 12739839 | 4 | 20160810 | 0 | ||
127398391 | 12739839 | 5 | 20160828 | 0 |